THE COST-EFFECTIVENESS OF THREE PREVENTION STRATEGIES IN ALZHEIMER'S DISEASE: RESULTS FROM THE MULTIDOMAIN ALZHEIMER PREVENTIVE TRIAL (MAPT) • The Journal of Prevention of Alzheimer's Disease
Cost-effectiveness of TLC-NOSF dressings versus neutral dressings for the treatment of diabetic foot ulcers in France | PLOS ONE
Nouvelle indemnisation transparente pour les médicaments soumis à ordonnance | Communauté d'achat HSK SA
PDF) The economic burden of urinary tract infections in women visiting general practices in France: A cross-sectional survey
PowerPoint 簡報
Competition From Biosimilars Drives Price Reductions For Biologics In The French Single-Payer Health System | Health Affairs
Cost-utility analysis of atezolizumab with bevacizumab in untreated unresectable or advanced hepatocellular carcinoma in France | PLOS ONE
La libre fixation des prix des médicaments financés dans les groupes homogènes de séjour hospitalier : une exception au régime des prix administrés des médicaments à conserver ? | Cairn.info
Hepatitis B or Delta liver transplant patients at risk of recurrence: Long-term effectiveness and budget impact of low-dose subcutaneous anti-hepatitis B immunoglobulin plus patient education program - ScienceDirect
La base de données médicaments Thériaque - CNHIM
PDF) Health Care Resource Utilization and Costs among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France
Vaccines | Free Full-Text | Budget Impact Analysis of Fixed Dose Versus Weight-Based Dosing Regimen of Nivolumab and Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer
Full article: A comparative public health and budget impact analysis of pneumococcal vaccines: The French case
Supplementary materials Methods Calculation of costs and HCRU A cost of €24.13, which included official tariffs and surcharges
POMME: The New Cohort to Evaluate Long-Term Effects After Prenatal Medicine Exposure | SpringerLink
THE COST-EFFECTIVENESS OF THREE PREVENTION STRATEGIES IN ALZHEIMER'S DISEASE: RESULTS FROM THE MULTIDOMAIN ALZHEIMER PREVENTIVE TRIAL (MAPT) • The Journal of Prevention of Alzheimer's Disease
La base de données médicaments Thériaque - CNHIM
OFFRE D'EMPLOI : Responsable Technico-Commercial en Transit (H/F) - Africa Supply Chain
L/6589/Add.2 Addendum couvert du document L/6589/Add.1. La traduction non officielle de cette en el documents L/6589/Add.l. La t
PandaLab | La messagerie médicale au coeur de votre pratique
Patient access to orphan drugs in France | Orphanet Journal of Rare Diseases | Full Text
utilisation des médicaments dans les maisons de soins - KCE
Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Experienced (TE) Patients in France | PLOS ONE
8 remèdes au prix élevé des médicaments | Paperjam News
Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from France - Erin Johansson, Anders Gustavsson, Carolin Miltenburger, Korinna Karampampa, Lucien Rumbach, Karin Rérat, Celine Thonnelier, 2012
Marge sur les médicaments - Comparaison avec l'étranger, Conférence de presse santésuisse, 23 novembre 2011
Hepatitis B or Delta liver transplant patients at risk of recurrence: Long-term effectiveness and budget impact of low-dose subcutaneous anti-hepatitis B immunoglobulin plus patient education program - ScienceDirect
